Phospholipase A(2) inhibitor–loaded micellar nanoparticles attenuate inflammation and mitigate osteoarthritis progression

Treating osteoarthritis (OA) remains a major clinical challenge. Despite recent advances in drug discovery and development, no disease-modifying drug for knee OA has emerged with any notable clinical success, in part, due to the lack of valid and responsive therapeutic targets and poor drug delivery...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Adv
Egile Nagusiak: Wei, Yulong, Yan, Lesan, Luo, Lijun, Gui, Tao, Jang, Biang, Amirshaghaghi, Ahmad, You, Tianyan, Tsourkas, Andrew, Qin, Ling, Cheng, Zhiliang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Association for the Advancement of Science 2021
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026133/
https://ncbi.nlm.nih.gov/pubmed/33827816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.abe6374
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak